Presenting Companies Announced for 11th Annual BIO Investor Forum.September 10, 2012 -
BIO announced private and public companies that will be presenting at 11th Annual BIO Investor Forum, which will take place October 9-10, 2012 in San Francisco, CA. Companies were chosen via competitive screening process with input from BIO and event's advisory committee. With focus on venture-stage growth and emerging public companies as well as those poised to join growth watch list in 2013, international investor forum explores investment trends and opportunities in life sciences.
BIO Announces Presenting Companies for 11th Annual BIO Investor Forum
Biotechnology Industry Organization
1201 Maryland Ave., SW, Ste. 900
Washington, DC, 20024
Press release date: September 6, 2012
Investor Forum will be held October 9-10, 2012 in San Francisco, CA
2012:Biotechnology Industry Organization WASHINGTON--The Biotechnology Industry Organization (BIO) announces the initial list of presenting companies for the 11th Annual BIO Investor Forum, an international investor forum which explores investment trends and opportunities in life sciences, with a focus on venture-stage growth and emerging public companies as well as those poised to join the growth "watch list" in 2013. The event will take place October 9-10, 2012 at the Palace Hotel in San Francisco, Calif.
"The aim of the BIO Investor Forum is to bring together a select group of private and early stage biotech companies along with leading investors in an effort to establish relationships and foster the development of new partnerships and, ultimately, new medicines. This year, we already have an exciting line-up of companies who will present their innovative products and technologies, from emerging public companies working on late-stage clinical trials, to newly-established Discovery companies developing novel biologics platforms," said Alan Eisenberg, executive vice president, Emerging Companies & Business Development at BIO.
Companies were chosen through a competitive screening process with input from BIO and the event's advisory committee. The committee is comprised of members from top-tier firms focused on investing and banking in the life sciences industry in addition to executives from emerging and leading biotech companies.
The following companies will present at the 11th Annual BIO Investor Forum:
Acetylon Pharmaceuticals Affimed Therapeutics AG AlloCure Inc. Altheus Therapeutics Ambit Biosciences bluebird bio Celtaxsys Ceregene Chimerix Collegium Pharmaceutical Colucid Pharmaceuticals Contrafect Corporation Cylene Pharmaceuticals Dicerna Pharmaceuticals Epizyme FORMA Therapeutics Galleon Pharmaceuticals GlycoMimetics Immune Design Corp. Immune Targeting Systems Ltd. Intarcia Therapeutics Intrexon Corporation KemPharm, Inc. KineMed Lipocine MabVax Therapeutics Metabolex Metabolon Midatech Group Ltd. Neurotez NexBio NOXXON Pharma AG Profil Institute for Translational Medicine Promedior Prosensa Therapeutics ProtAffin Biotechnologie AG Protagonist Therapeutics, Inc. Proteostasis Therapeutics Sage Therapeutics Sutro Biopharma Tetraphase Pharmaceuticals TheraVida TissueGene Trellis Bioscience, LLC Ultragenyx Pharmaceutical Zafgen Zosano Pharma
AcelRx Pharmaceuticals Addex Therapeutics Advaxis ADVENTRX Pharmaceuticals Allon Therapeutics Aradigm Corporation Astex Pharmaceuticals Benitec Biopharma Ltd. Bio-Path Holdings BioSante Pharmaceuticals Circadian Technologies Limited Cyclacel Pharmaceuticals Durata Therapeutics Galena Biopharma GenVec Horizon Pharma Immunovaccine Karolinska Development AB MEI Pharma Resverlogix Corp. Senesco Technologies Sophiris Bio Spectrum Pharmaceuticals SymBio Pharmaceuticals Limited Threshold Pharmaceuticals Transgene SA Tranzyme Pharma ZIOPHARM Oncology
Now a staple at the Investor Forum, the event will once again feature a series of Discovery Track presentations. The presentations will focus on Seed and A-round companies incorporated after 2007 that have raised less than $25M total through October 2012. Companies in this track are also first-time presenters and use biotechnology or related technologies for research and development of drug products or diagnostics. The following companies are scheduled to present in the Private - Discovery Track:
Applied Microarrays Arrogene Déclion Pharmaceuticals Eqalix HeatFlow Technologies Immunome Immunomic Inception Sciences InnoBioscience LoneStar Heart, Inc. NTpharma LLC Omniox Regenesance BV Retrophin LLC Serina Therapeutics Susavion Biosciences, Inc. Tunitas Therapeutics Wellesley Pharmaceuticals Xalud Therapeutics
Check back often as new presenters are continuously being added. If you are interested in becoming a presenter, please submit an application here.
The BIO Investor Forum is a must attend event for public and private market investors, research analysts, investment bankers, and industry executives focused on investment and business development opportunities in the life sciences. BIO One-on-One Partnering(TM) will also provide an opportunity to arrange meetings between investors; companies; and industry business development, licensing and therapeutic franchise heads.
To learn more about the BIO Investor Forum, including registration and program information, please visit here. Registration is complimentary for credentialed members of the media and qualified investors.
BIO is pleased to recognize the leadership provided by the BIO Investor Forum Conference sponsors including Supporting Banks Stifel, Nicolaus & Company, and Roth Capital. BIO Double Helix and Helix Sponsors include Abbott Biotech Ventures, Amgen Ventures, Baxter Ventures, J&J Development Corporation, MedImmune Ventures, GlaxoSmithKline, Merck, and Pfizer.
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, an online portal and monthly newsletter chronicling "innovations transforming our world." Subscribe to BIOtechNOW.